Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Nautilus Biotechnology (NASDAQ:NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience Inc (NASDAQ:HBIO), Codexis Inc (NASDAQ:CDXS), Lifecore Biomedical Inc (NASDAQ:LFCR), Quanterix Corp (NASDAQ:QTRX) and CDT Equity Inc (NASDAQ:CDT).
Nautilus Biotechnology has a consensus price target of $4.19.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $1.9316 last updated December 12, 2025 at 6:50 PM EST.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.